Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: first in vivo evidence

Dades bibliogràfiques
Autors principals:	Cerdeira, AS, Kandzija, N, Pargmae, P, Cooke, W, James, T, Redman, C, Vatish, M
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2019

In vivo evidence of significant placental growth factor release by normal pregnancy placentas
per: Cerdeira, A, et al.
Publicat: (2020)

Circulating SFLT-1 is placentally derived in normal pregnancy
per: Cerdeira, A, et al.
Publicat: (2018)

Predictive accuracy of soluble FMS-like tyrosine kinase-1/placental growth factor ratio for preeclampsia in Japan: a systematic review
per: Yamazaki, T, et al.
Publicat: (2020)

Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: The SaPPPhirE Study.
per: Agrawal, S, et al.
Publicat: (2017)

Differences Ratio Level Soluble FMS-Like Tyrosine Kinase-1 and Placental Growth Factor Early And Late Onset on Preeclampsia and Normal Pregnancy
per: Ria Andina, et al.
Publicat: (2018-06-01)

Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia
per: Zeisler, H, et al.
Publicat: (2016)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
per: Nesreen Nasser, et al.
Publicat: (2020-12-01)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
per: Kifle, MM, et al.
Publicat: (2022)

The ratio of soluble fms–like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia- a secondary analysis of the INSPIRE trial
per: Palma Dos Reis, CR, et al.
Publicat: (2024)

One step closer to a cure for preeclampsia? Boosting the natural affinity of VEGF (vascular endothelial growth factor) to sFlt (soluble fms-like tyrosine kinase)-1
per: Cerdeira, AS, et al.
Publicat: (2020)

Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
per: Rajakumar, A, et al.
Publicat: (2012)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
per: Meron M. Kifle, et al.
Publicat: (2022-06-01)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
per: Vorapong Phupong, et al.
Publicat: (2020-04-01)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
per: Alaa Raeed, et al.
Publicat: (2024-04-01)

Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting
per: Zeisler, H, et al.
Publicat: (2019)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
per: Carmen Rădulescu, et al.
Publicat: (2016-01-01)

Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia
per: Cerdeira, AS, et al.
Publicat: (2021)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
per: Jiawu Zhao, et al.
Publicat: (2024-01-01)

Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD
per: Zsuzsanna K. Zsengellér, et al.
Publicat: (2019-12-01)

Antiangiogenic Biomarker Soluble Fms-like Tyrosine Kinase-1 in Pregnancy Complicated with Preeclampsia: A Cohort Study
per: Mandeep Kaur, et al.
Publicat: (2021-12-01)

Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review
per: Hadfield Ruth, et al.
Publicat: (2011-06-01)

Evaluation of Soluble Fms-like Tyrosine Kinase-1 in First Trimester of Pregnancy: A Cross-sectional Study
per: Sathya Selvarajan, et al.
Publicat: (2019-12-01)

Elevated neprilysin in placental vesicles derived from preeclamptic pregnancies
per: Gill, M, et al.
Publicat: (2018)

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia
per: Mahmoud Fathy Hassan, et al.
Publicat: (2013-01-01)

Reference Intervals for the ratio of Soluble FMS-like Tyrosine Kinase-1 and Placental Growth Factor in Pregnant and Non-Pregnant Females in Pakistani Population
per: Asma Afaaq, et al.
Publicat: (2024-09-01)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
per: Roxanne Hastie, et al.
Publicat: (2022-08-01)

CORRELATION BETWEEN FMS-LIKE TYROSINE KINASE-1 (SFLT-1) CELL-FREE MESSENGER RNA EXPRESSION AND FMS-LIKE TYROSINE KINASE-1 (SFLT-1) PROTEIN LEVEL IN SEVERE PREECLAMPSIA AND NORMAL PREGNANCY
per: Jeffry Iman Gurnadi, et al.
Publicat: (2015-09-01)

The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients
per: Lai C, et al.
Publicat: (2025-03-01)

Pengaruh Likopen terhadap Kadar Soluble FMS-Like Tyrosine Kinase 1 pada Preeklamsi
per: Vaulinne Basyir, et al.
Publicat: (2021-02-01)

Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
per: Lissette C. Sánchez-Aranguren, et al.
Publicat: (2018-03-01)

Association between serum soluble fms-like tyrosine kinase-1 and the central choroidal thickness during pregnancy: a prospective study
per: Ryo Asaoka, et al.
Publicat: (2021-09-01)

Soluble fms-like tyrosine kinase-1 and vascular endothelial growth factor: Novel markers for unexplained early recurrent pregnancy loss
per: Mahmoud Fathy Hassan
Publicat: (2014-03-01)

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis
per: Geoff K Frampton, et al.
Publicat: (2016-11-01)

Placental syncytiotrophoblast-derived extracellular vesicles carry active NEP (neprilysin) and are increased in preeclampsia
per: Gill, M, et al.
Publicat: (2019)

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
per: Vincent Dupont, et al.
Publicat: (2022-10-01)

Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.
per: Verlohren, S, et al.
Publicat: (2008)

Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms‐Like Tyrosine Kinase‐1/Placental Growth Factor Ratio
per: Cornelia H. Quaak, et al.
Publicat: (2024-04-01)

Role of soluble fms-like tyrosine kinase-1/placental growth factor ratio along with uterine artery Doppler for the prediction of pre-eclampsia – A case–control study
per: Sathya Jagdish, et al.
Publicat: (2024-05-01)

Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction
per: Satoshi Shinohara, et al.
Publicat: (2017-07-01)

The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience
per: Andrijana Müller, et al.
Publicat: (2019-02-01)

Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: first in vivo evidence

Ítems similars

Ítems similars